Ansun Biopharma to Pay More Than $2 Million for Overbilling the U.S.
United States Attorney for the Southern District of California Laura E. Duffy announced that a local biopharmaceutical company, Ansun Biopharma, Inc., entered into criminal and civil settlements with the Department of Justice that will require it to make approximately $2 million in payments to the United States. These settlements resolve a criminal and related civil investigation against Ansun for submitting false and fraudulent claims on grants and a contract with the National Institutes of Health ("NIH").
- Date:January 7, 2015
- Agency:U.S. Attorney
- Criminal and Civil Actions